BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020

Sep 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-08-31

Reporting Person: PYOTT DAVID E I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-31	Common Stock	P	11900	$78.2151	Acquired	29840	Direct
2020-08-31	Common Stock	P	900	$78.8393	Acquired	30740	Direct

Footnotes

F1: The price in column 4 is the weighted average price. The actual purchase price paid ranged from $77.78 to $78.76. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.

F2: The price in column 4 is the weighted average price. The actual purchase price paid ranged from $78.78 to $78.91. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.